Skip to content
Resources

HELPFUL RESOURCES FOR COPING WITH AGITATION

Download educational information

IGALMI Patient Brochure

This educational brochure provides information on how IGALMI works to reduce agitation related to bipolar disorderschizophrenia, how to take IGALMI, and more.

Download PDF Download PDF

Agitation Action Plan

The Agitation Action Plan can help you prepare for a potential agitation episode. It can help you better understand what to look out for and how best to cope.

Download PDF Download PDF

Apply to be a B.E.A.C.O.N. Program Ambassador and share your story

You are not alone, and others may relate to or be inspired by your experience. Your story could be exactly what they want to hear. Through the B.E.A.C.O.N. Program, you may have the opportunity to share your experience with IGALMI in a number of different internal and external ways including through written stories, videos, social media posts, or in-person meetings. Participation is completely voluntary, and you may opt out at any time.

Interested in learning more? Contact the B.E.A.C.O.N. Program today!

Online resources for real-time support

Whether you have a large support network or not, it’s important to know that there are resources available to help. Check out the organizations below. You can also speak with your doctor for help finding support services in your area.

Schizophrenia & Psychosis Action Alliance

The Schizophrenia & Psychosis Action Alliance offers peer-based support for people living with schizophrenia and schizophrenia-related illness, as well as education and resources.

Visit Site

Students With Psychosis

Students With Psychosis is a nonprofit organization specifically aimed at supporting college students who live with schizophrenia and other forms of psychosis, through a facilitated learning program and other online resources.

Visit Site

Schizophrenia.com

Schizophrenia.com is an internet community dedicated to providing information, support, and education to family members, caregivers, and individuals whose lives are impacted by schizophrenia.

Visit Site

National Alliance on Mental Illness (NAMI)

NAMI provides advocacy, education, support, and public awareness for individuals and families affected by mental illness.

Visit Site

National Alliance on Mental Illness (NAMI)

NAMI provides advocacy, education, support, and public awareness for individuals and families affected by mental illness.

Visit NAMI

Depression and Bipolar Support Alliance (DBSA)

DBSA offers peer-based support for people living with mood disorders, including bipolar disorder, through online resources and local support groups. It has chapters and facilities all over the United States.

Visit DBSA

bphope.com

bphope.com is an online community for people living with bipolar disorder, as well as their friends and families, and for anyone seeking support. You can read and comment on articles and blogs that cover a large number of topics about bipolar disorder.

Visit bphope.com

This is not a complete list of available support groups. BioXcel Therapeutics, Inc. does not recommend or endorse any specific support group.

Read More
Collapse

IMPORTANT SAFETY INFORMATION

IGALMI can cause serious side effects, including:
  • Decreased blood pressure, low blood pressure upon standing, and slower than normal heart rate, which may be more likely in patients with low blood volume, diabetes, chronic high blood pressure, and older patients. IGALMI is taken under the supervision of a healthcare provider who will monitor your vital signs (like blood pressure and heart rate) and alertness after you take IGALMI to prevent you from falling or fainting. Make sure you are adequately hydrated and sit or lie down after taking IGALMI. Tell your healthcare provider if you feel dizzy, lightheaded, or faint.

WHAT IS IGALMI?

IGALMI™ (dexmedetomidine) sublingual film is a prescription medicine that is placed under your tongue or behind your lower lip and is used for the acute treatment of agitation associated with bipolar disorder I or IIschizophrenia in adults. The safety and effectiveness of IGALMI has not been studied beyond 24 hours from the first dose. It is not known if IGALMI is safe and effective in children.

  • Heart rhythm changes (QT interval prolongation). You should not take IGALMI if you have an abnormal heart rhythm, a history of an irregular heartbeat, slow heart rate, low potassium, low magnesium, and if you are taking other drugs that affect your heart rhythm. Taking IGALMI if you have a history of abnormal heart rhythm can increase the risk of torsades de pointes and sudden death. Tell your healthcare provider immediately if you feel faint or have heart palpitations.
  • Sleepiness/drowsiness. Do not do activities requiring mental alertness, such as driving or operating hazardous machinery, for at least 8 hours after taking IGALMI.
  • Withdrawal reactions, tolerance, and decreased response/efficacy. IGALMI was not studied for longer than 24 hours after the first dose. Physical dependence, withdrawal symptoms (e.g., nausea, vomiting, agitation), and decreased response to IGALMI may occur if IGALMI is used longer than 24 hours.

The most common side effects of IGALMI in clinical studies were sleepiness or drowsiness, a prickling or tingling sensation or numbness of the mouth, dizziness, dry mouth, low blood pressure, and low blood pressure upon standing.

These are not all the possible side effects of IGALMI. Speak with your healthcare provider for medical advice about side effects.

Tell your healthcare provider about your medical history, including if you suffer from any known heart problems, low potassium, low magnesium, low blood pressure, low heart rate, diabetes, high blood pressure, history of fainting, or liver impairment. Tell your healthcare provider if you are pregnant or breastfeeding or take any medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take any drugs that lower your blood pressure, change your heart rate, or take anesthetics, sedatives, hypnotics, and opioids.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088. You can also contact BioXcel Therapeutics, Inc. at 1-833-201-1088 or medinfo@bioxceltherapeutics.com.

Please see full Prescribing Information.

WHAT IS IGALMI?

IGALMI™ (dexmedetomidine) sublingual film is a prescription medicine that is placed under your tongue or behind your lower lip and is used for the acute treatment of agitation associated with bipolar disorder I or IIschizophrenia in adults. The safety and effectiveness of IGALMI has not been studied beyond 24 hours from the first dose. It is not known if IGALMI is safe and effective in children.